Medicxi Ventures Management Jersey Ltd Makes New Investment in NewAmsterdam Pharma (NASDAQ:NAMS)

Medicxi Ventures Management Jersey Ltd purchased a new position in shares of NewAmsterdam Pharma (NASDAQ:NAMS – Get Rating) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 2,000,000 shares of the company’s stock, valued at approximately $21,800,000. NewAmsterdam Pharma comprises approximately 9.2% of Medicxi Ventures […]

Related Keywords

Newamsterdam Pharma ,William Blair ,Jefferies Financial Group ,Credit Suisse Group ,Exchange Commission ,Newamsterdam Pharma Company ,Medicxi Ventures Management Jersey Ltd ,Get Rating ,Amsterdam Pharma ,Ventures Management Jersey Ltd ,Suisse Group ,Visit Holdingschannel ,Newamsterdam Pharma Daily ,Nasdaq Nams ,Adnams ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,